Bank of Montreal Can Purchases 421 Shares of Innophos Holdings, Inc. (NASDAQ:IPHS)

0
18

Bank of Montreal Can lifted its position in Innophos Holdings, Inc. (NASDAQ:IPHS) by 18.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,747 shares of the specialty chemicals company’s stock after acquiring an additional 421 shares during the period. Bank of Montreal Can’s holdings in Innophos were worth $88,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. NEXT Financial Group Inc raised its position in shares of Innophos by 87.8% in the 4th quarter. NEXT Financial Group Inc now owns 813 shares of the specialty chemicals company’s stock worth $26,000 after acquiring an additional 380 shares in the last quarter. Tower Research Capital LLC TRC raised its position in shares of Innophos by 471.9% in the 3rd quarter. Tower Research Capital LLC TRC now owns 1,384 shares of the specialty chemicals company’s stock worth $45,000 after acquiring an additional 1,142 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Innophos in the 4th quarter worth approximately $61,000. PNC Financial Services Group Inc. raised its position in shares of Innophos by 18.1% in the 4th quarter. PNC Financial Services Group Inc. now owns 2,052 shares of the specialty chemicals company’s stock worth $66,000 after acquiring an additional 315 shares in the last quarter. Finally, HGK Asset Management Inc. raised its position in shares of Innophos by 18.8% in the 4th quarter. HGK Asset Management Inc. now owns 7,160 shares of the specialty chemicals company’s stock worth $229,000 after acquiring an additional 1,134 shares in the last quarter. 92.47% of the stock is owned by hedge funds and other institutional investors.

Several analysts recently weighed in on the company. ValuEngine upgraded Innophos from a “sell” rating to a “hold” rating in a research note on Tuesday, February 4th. Zacks Investment Research upgraded Innophos from a “sell” rating to a “hold” rating in a research note on Wednesday, January 1st. Finally, BidaskClub downgraded Innophos from a “sell” rating to a “strong sell” rating in a research note on Saturday, January 11th.

Shares of IPHS opened at $31.99 on Thursday. The business’s fifty day simple moving average is $31.99 and its two-hundred day simple moving average is $32.08. The company has a current ratio of 2.94, a quick ratio of 1.48 and a debt-to-equity ratio of 1.01. Innophos Holdings, Inc. has a 12 month low of $23.85 and a 12 month high of $37.53. The company has a market cap of $629.88 million, a price-to-earnings ratio of 29.90 and a beta of 1.48.

About Innophos

Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company’s specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.

Further Reading: Why is insider trading harmful?

Institutional Ownership by Quarter for Innophos (NASDAQ:IPHS)



Receive News & Ratings for Innophos Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Innophos and related companies with MarketBeat.com’s FREE daily email newsletter.

LEAVE A REPLY

Please enter your comment!
Please enter your name here